Repeat region of Brugia malayi sheath protein (Shp-1) carries Dominant B epitopes recognized in filarial endemic population

• Autorzy: Jawaharlal J.P.P. , Madhumathi J. , Prince R. P. , Kaliraj P.
• Języki publikacji: EN

Abstrakty

EN

Transmission of lymphatic filariasis is mediated through microfilariae (L1 stage of the parasite) which is encased in an eggshell called sheath. The sheath protein Shp-1 stabilizes the structure due to the unique repeat region with Met-Pro-Pro-Gln-Gly sequences. Microfilarial proteins could be used as transmission blocking vaccines. Since the repeat region of Shp-1 was predicted to carry putative B epitopes, this region was used to analyze its reactivity with clinical samples towards construction of peptide vaccine. In silico analysis of Shp-1 showed the presence of B epitopes in the region 49–107. The polypeptide epitopic region Shp-149–107 was cloned and expressed in Escherichia coli. Antibody reactivity of the Shp-149–107 construct was evaluated in filarial endemic population by ELISA. Putatively immune endemic normals (EN) showed significantly high reactivity (P < 0.05) when compared to all the other categories. Antibody reactivity of Shp-1 repeat region was similar to that of whole protein proving that this region carries B epitopes responsible for its humoral response in humans. Thus this can be employed for inducing anti-microfilarial immunity in the infected population that may lead to reduction in transmission intensity and also it could be used along with other epitopes from different stages of the parasite in order to manage the disease effectively.

Słowa kluczowe

EN

lymphatic filariasis; sheath protein; Brugia malayi; epitope; endemic population; peptide vaccine; protein sequence

• Wydawca: -
• Czasopismo: Acta Parasitologica
• Rocznik: 2014
• Tom: 59
• Numer: 3
• Opis fizyczny: p.454-458,fig.,ref.

Twórcy

autor

Jawaharlal J.P.P.

• Centre for Biotechnology, Anna University, Chennai, Tamil Nadu, India

autor

Madhumathi J.

• Centre for Biotechnology, Anna University, Chennai, Tamil Nadu, India

autor

Prince R. P.

• Centre for Biotechnology, Anna University, Chennai, Tamil Nadu, India

autor

Kaliraj P.

• Centre for Biotechnology, Anna University, Chennai, Tamil Nadu, India

Bibliografia

• Aboobaker A.A. and Blaxter M.L. 2003. Use of RNA interference to investigate gene function in the human filarial nematode parasite Brugia malayi. Molecular and Biochemical Parasitology, 129, 41–51. DOI: 10.1016/S0166-6851(03)00092-6.
• Abraham D., Grieve R.B., Holy J.M., Christensen B.M., 1989. Immunity to larval Brugia malayi in BALB/c mice: protective immunity and inhibition of larval development. The American Journal of Tropical Medicine and Hygiene, 40, 598–604.
• Ballou W.R., Rothbard J. et al. 1985. Immunogenicity of synthetic peptides from circumsporozoite protein of Plasmodium falciparum. Science, 228, 996–999. DOI: 10.1126/science. 2988126.
• Chandrashekar R., Rao U.R., Parab P.B., Subrahmanyam D. 1985. Brugia malayi: serum dependent cell-mediated reactions to microfilariae. Southeast Asian Journal of Tropical Medicine and Public Health, 16, 15–21.
• Chandrashekar R., Rao U.R., Subrahmanyam D. 1990. Antibodymediated cytotoxic effects in vitro and in vivo of rat cells on infective larvae of Brugia malayi. International Journal for Parasitology, 20, 725–30.
• Christ H., Hirzmann J., Conraths F., Zahner H., Stirm S., Hobom G. 1992. Trans-splicing of an early embryo mRNA in Litomosoides carinii, coding for the major microfilarial sheath protein gp22. Gene, 121, 219–226. DOI: 10.1016/0378-111 990125-9.
• Dabir S., Dabir P., Goswami K., Reddy M.V. 2008. Prophylactic evaluation of recombinant extracellular superoxide dismutase of Brugia malayi in jird model. Vaccine, 26, 3705–3710. DOI:10.1016/j.vaccine.2008.04.061.
• Horii T., Shirai H. et al. 2010. Evidences of protection against bloodstage infection of Plasmodium falciparum by the novel protein vaccine SE36. Parasitology International, 59, 380–386. DOI:10.1016/j.parint.2010.05.002.
• Jawaharlal J.P., Ravishankaran R., Shridharan R.N., Lawrence A.V., Karande A.A., Perumal K. 2014. Evaluation of Brugia malayi sheath protein (Shp-1) as a diagnostic antigen for human lymphatic filariasis. Diagnostic Microbiology and Infectious Disease, 78, 249–254. DOI:10.1016/j.diagmicrobio.2013.11.019.
• Madhumathi J., Prince P.R., Anugraha G., Kiran P., Rao D.N., Reddy M.V., Kaliraj P. 2010b. Identification and characterization of nematode specific protective epitopes of Brugia malayi TRX towards development of synthetic vaccine construct for lymphatic filariasis. Vaccine, 28, 5038–5048. DOI:10.1016/j.vaccine.2010.05.012.
• Mahajan B., Berzofsky J.A. et al. 2010. Multiple antigen peptide vaccines against Plasmodium falciparum malaria. Infection and Immunity, 78, 4613–4624. DOI: 10.1128/IAI.00533-10.
• McGreevy P.B., Ratiwayanto S., Tuti S., McGreevy M.M., Dennis D.T. 1980. Brugia malayi: relationship between anti-sheath antibodies and amicrofilaremia in natives living in an endemic area of South Kalimantan, Borneo. American Journal of Tropical Medicine and Hygiene, 29, 553–562.
• Peters B., Sidney J. et al. 2005. The design and implementation of the immune epitope database and analysis resource. Immunogenetics, 57, 326–336. DOI: 10.1007/s00251-005-0803-5.
• Ravindran B., Satapathy A.K., Sahoo P.K., Babu Geddam J.J. 2000. Protective immunity in human Bancroftian filariasis: inverse relationship between antibodies to microfilarial sheath and circulating filarial antigens. Parasite Immunology, 22, 633–637. DOI: 10.1046/j.1365-3024.2000.00347.x.
• Selkirk M.E., Yazdanbakhsh M., Freedman D., Blaxter M.L., Cookson E., Jenkins R.E., Williams S.A. 1991. A proline-rich structural protein of the surface sheath of larval Brugia filarial nematode parasites. The Journal of Biological Chemistry, 266, 11002–11008.
• Singh B., Cabrera-Mora M., Jiang J., Moreno A. 2012. A hybrid multistage protein vaccine induces protective immunity against murine malaria. Infection and Immunity, 80, 1491–1501. DOI: 10.1128/IAI.05980-11.
• Steel C., Ottesen E.A., Weller P.F., Nutman T.B. 2001. Worm burden and host responsiveness in Wuchereria bancrofti infection: use of antigen detection to refine earlier assessments from the South Pacific. American Journal of Tropical Medicine and Hygiene, 65, 498–503.
• Wadee A.A., Vickery A.C., Piessens W.F. 1987. Characterization of immunosuppressive proteins of Brugia malayi microfilariae. Acta Tropica, 44, 343–352.
• Wang S., Zheng H., Tao Z., Piessens W.F. 1999. [Studies on recombinant chitinase and SXP-1 antigens as antimicrofilarial vaccines]. Chinese Journal of Parasitology and Parasitic Diseases, 17, 90–94.
• Wang S.H., Zheng H.J., Dissanayake S., Cheng W.F., Tao Z.H., Lin S.Z., Piessens W.F. 1997. Evaluation of recombinant chitinase and SXP1 antigens as antimicrofilarial vaccines. American Journal of Tropical Medicine and Hygiene, 56, 474–481.
• WHO (World Health Organization). 2013. Towards eliminating lymphatic filariasis: progress in the South-East Asia Region (2001–2011). WHO Regional office for South East Asia.